Threshold Pharmaceuticals, Inc. to Present at the 10th Annual JMP Securities Research Conference

REDWOOD CITY, Calif., May 9, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced that Dr. Barry Selick, Threshold’s chief executive officer, will present at the 10th Annual JMP Securities Research Conference on Tuesday, May 10, at 4:00 p.m. Pacific Time at the Ritz Carlton in San Francisco, CA. The Company will provide an overview of its clinical development program.

MORE ON THIS TOPIC